March 31, 2017

The company will be dispensing atopic dermatitis drug Dupixent (dupilumab) and the limited-distribution multiple sclerosis treatment Ocrevus (ocrelizumab).

March 31, 2017

The 80mg once-daily tablets are intended for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

March 28, 2017

ORIEN Avatar fosters collaboration among key stakeholders in cancer research with the shared goal of discovering and developing novel therapies in clinical trials.

March 28, 2017

Dr. Ajit Shetty has 36 years of pharmaceutical industry experience, first joining Janssen Pharmaceutica in 1976.

March 27, 2017

Joint arrangement expected to allow Novartis to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.

March 27, 2017

Paul Bisaro previously served as executive chairman of Allergan, and president, CEO and chairman of the board of Actavis.

March 21, 2017

Some of the difficult-to-treat conditions may include cancer, hepatitis B and C, HIV, rheumatoid arthritis and a host of other medical conditions requiring very specialized medications and therapy regimens.

March 17, 2017

The specialty pharmacy will dispense Kisqali, which was recently approved by the Food and Drug Administration. 

March 17, 2017

Patients taking Genentech drug can live an average of 2.47 years longer than those with best supportive care treatment, research concludes.

March 7, 2017

Mike Agostino will return as president to Amber Pharmacy as Aaron Wiese leaves the position to become Hy-Vee VP strategy/innovation. 

March 6, 2017

DSN examines chain pharmacy, including in-depth coverage of the specialty market, in this multi-page report.

March 6, 2017

Specialty and biotech medicines aimed at treating cancer, multiple sclerosis and rare diseases will dominate much of drug development in 2017 and beyond, one of the nation’s top specialty pharmacy providers concluded.

March 6, 2017

Among the 22 novel new drugs approved by the Food and Drug Administration in 2016, about half were considered specialty drugs.

March 2, 2017

Epic will help integrate and improve clinical processes for CVS Specialty, including Accordant, which provides care management program services for patients with rare, chronic diseases.

March 2, 2017

Memphis-based company is seeing continued improvement in its retail and specialty pharmacy divisions. 

February 22, 2017

The pharmacy staff at cancer-specialized specialty pharmacies have completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers.

February 3, 2017

The Pharmaceutical Research and Manufacturers of America has announced leadership changes to some of its advocacy efforts as longtime SVP advocacy Jeff Bond is set to retire. 

February 2, 2017
Diplomat acquired the company for $16 million in cash and up to an additional $4 million in contingent payments. 
February 2, 2017

Winter weather events, a slow cold and flu season and continued reimbursement pressure affected overall sales for Q4, fiscal year 2016 and January, however.

February 1, 2017

Johnson & Johnson worldwide chairman, pharmaceuticals Joaquin Duato was elected chairman of the board, Novartis CEO Joseph Jimenez was elected chairman-elect and Amgen chairman and CEO Robert Bradway was named board treasurer.

January 27, 2017

Despite not seeking accelerated regulatory approval, company is moving forward with its development.

January 27, 2017

The new Walgreens specialty pharmacies are part of more than 250 Walgreens community and health system pharmacies that focus on community-based, patient-centered care.

January 26, 2017

Actelion will spin off its drug discovery operations and early-stage clinical development assets into a newly created company to its shareholders in the form of a dividend immediately prior to the deal closing.

January 23, 2017

The campaign is aimed at highlighting those in the industry driving innovation and pointing to the opportunity that exists in tackling complex health conditions.